GOLDBERG MORTON 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Feb 3, 2021
Insider Transaction Report
Form 4
GOLDBERG MORTON
Director
Transactions
- Award
Stock Option (right to buy)
2021-02-01+3,333→ 3,333 totalExercise: $6.46Exp: 2031-02-01→ Common Stock (3,333 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2022.